Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease

European Journal of Neuroscience

Volumn 31, Issue 11, 2010, Pages 2024-2031

  Schmitz, Matthias ^a   Schlomm, Markus ^b   Hasan, Badrul ^a   Beekes, Michael ^c   Mitrova, Eva ^d   Korth, Carsten ^e   Breil, Andreas ^e   Carimalo, Julie ^a   Gawinecka, Joanna ^a   Varges, Daniela ^a   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c ROBERT KOCH INSTITUTE   (Germany)

^d SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antibodies; CJD; CSF; Isoform composition; PrPc

Indexed keywords

PRION PROTEIN; CODON; ISOPROTEIN; MONOCLONAL ANTIBODY; PRION;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; CODON; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PRION; PROTEIN PROCESSING; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CODON; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PRIONS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; YOUNG ADULT;

EID: 77953184919     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07224.x     Document Type: Article

References (59)

1. Beringue, V., Mallinson, G., Kaisar, M., Tayebi, M., Sattar, Z., Jackson, G., Anstee, D., Collinge, J. Hawke, S. (2003) Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain, 126, 2065 2073.
2. Bieschke, J., Giese, A., Schulz-Schaeffer, W., Zerr, I., Poser, S., Eigen, M. Kretzschmar, H. (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl Acad. Sci. USA, 97, 5468 5473.
3. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.P., DeArmond, S.J., Prusiner, S.B., Aguet, M. Weissmann, C. (1992) Normal development and behaviour of mice lacking the meuromal cell-surface PrP protein. Nature, 356, 577 582.
4. Cali, I., Castellani, R., Yuan, J., Al-Shekhlee, A., Cohen, M.L., Xiao, X., Moleres, F.J., Parchi, P., Zou, W.Q. Gambetti, P. (2006) Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain, 129, 2266 2277.
5. Capellari, S., Parchi, P., Russo, C.M., Sanford, J., Sy, M.S., Gambetti, P. Petersen, R.B. (2000) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am. J. Pathol., 157, 613 622.
6. Castagna, A., Campostrini, N., Farinazzo, A., Zanusso, G., Monaco, S. Righetti, P.G. (2002) Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system. Electrophoresis, 23, 339 346.
7. Chen, S.G., Teplow, D.B., Parchi, P., Teller, J.K., Gambetti, P. Autilio-Gambetti, L. (1995) Truncated forms of the human prion protein in normal brain and prion diseases. J. Biol. Chem., 270, 19173 19180.
8. Chen, S., Mangé, A., Dong, L., Lehmann, S. Schachner, M. (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol. Cell. Neurosci., 22, 227 233.
9. Choi, E.M., Geschwind, M.D., Deering, C., Pomeroy, K., Kuo, A., Miller, B.L., Safar, J.G. Prusiner, S.B. (2009) Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease. Lab. Invest., 89, 624 635.
10. Cissé, M.A., Sunyach, C., Lefranc-Jullien, S., Postina, R., Vincent, B. Checler, F. (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem., 280, 40624 40631.
11. Collins, S.J., Sanchez-Juan, P., Masters, C.L., Klug, G.M., van Duijn, C., Poleggi, A., Pocchiari, M., Almonti, S., Cuadrado-Corrales, N., de Pedro-Cuesta, J., Budka, H., Gelpi, E., Glatzel, M., Tolnay, M., Hewer, E., Zerr, I., Heinemann, U., Kretzschmar, H.A., Jansen, G.H., Olsen, E., Mitrova, E., Alpérovitch, A., Brandel, J.P., Mackenzie, J., Murray, K. Will, R.G. (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain, 129, 2278 2287.
12. Funke, E., Birkmann, D. Willbold, D. (2009) Detection of amyloid-ß aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's Disease? Curr. Alzheimer Res., 6, 285 289.
13. Gambetti, P., Parchi, P. Chen, S.G. (2003a) Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. Clin. Lab. Med., 23, 43 64.
14. Gambetti, P., Kong, Q., Zou, W., Parchi, P. Chen, S.G. (2003b) Sporadic and familial CJD: classification and characterization. Br. Med. Bull., 66, 213 239.
15. Haraguchi, T., Fisher, S., Olofsson, S., Endo, T., Groth, D., Tarentino, A., Borchelt, D.R.A., Teplow, D., Hood, L. Burlingame, A. (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch. Biochem. Biophys., 274, 1 13.
16. Harris, D.A., Huber, M.T., van Dijken, P., Shyng, S.L., Chait, B.T. Wang, R. (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry, 32, 1009 1016.
17. Hill, A.F., Joiner, S., Beck, J.A., Campbell, T.A., Dickinson, A., Poulter, M., Wadsworth, J.D. Collinge, J. (2006) Distinct glycoforms ratios of protease resistant prion protein associated with PRNP point mutations. Brain, 129, 676 685.
18. Hsiao, K., Meiner, Z., Kahana, E., Cass, C., Kahana, I., Avrahami, D., Scarlato, G., Abramsky, O., Prusiner, S.B. Gabizon, R. (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N. Engl. J. Med., 324, 1091 1097.
19. Jiménez-Huete, A., Lievens, P.M., Vidal, R., Piccardo, P., Ghetti, B., Tagliavini, F., Frangione, B. Prelli, F. (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am. J. Pathol., 153, 1561 1572.
20. Korth, C., Streit, P. Oesch, B. (1999) Monoclonal antibodies specific for the native, disease-associated isoform of prion protein. Methods Enzymol., 309, 106 122.
21. Korth, C., Kaneko, K. Prusiner, S.B. (2000) Expression of unglycosylated mutated prion protein facilitates PrP (Sc) formation in neuroblastoma cells infected with different prion strains. J. Gen. Virol., 81, 2555 2563.
22. Kuczius, T., Grassi, J., Karch, H. Groschup, M.H. (2007a) Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse. FEBS J., 274, 1492 1502.
23. Kuczius, T., Koch, R., Keyvani, K., Karch, H., Grassi, J. Groschup, M.H. (2007b) Regional and phenotype heterogeneity of cellular prion proteins in the human brain. Eur. J. Neurosci., 25, 2649 2655.
24. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680 685.
25. Lawson, V.A., Collins, S.J., Masters, C.L. Hill, A.F. (2005) Prion protein glycosylation. J. Neurochem., 93, 793 801.
26. Ludewigs, H., Zuber, C., Vana, K., Nikles, D., Zerr, I. Weiss, S. (2007) Therapeutic approaches for prion disorders. Expert Rev. Anti Infect. Ther., 5, 613 630.
27. Mangé, A., Béranger, F., Peoc'h, K., Onodera, T., Frobert, Y. Lehmann, S. (2004) Alpha-and beta cleavages of the amino-terminus of the cellular prion protein. Biol. Cell, 96, 125 132.
28. Meyne, F., Gloeckner, S.F., Ciesielczyk, B., Heinemann, U., Krasnianski, A., Meissner, B. Zerr, I. (2009) Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J. Alzheimers Dis., 17, 863 873.
29. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J.L., Lehmann, S., Launay, J.M. Kellermann, O. (2000) Signal transduction through prion protein. Science, 289, 1925 1928.
30. Notari, S., Strammiello, R., Capellari, S., Giese, A., Cescatti, M., Grassi, J., Ghetti, B., Langeveld, J.P., Zou, W.Q., Gambetti, P., Kretzschmar, H.A. Parchi, P. (2008) Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J. Biol. Chem., 283, 30557 30565.
31. Pan, T., Li, R., Wong, B.S., Liu, T., Gambetti, P. Sy, M.S. (2002) Heterogeneity of normal prion protein in two-dimensional immunoblot: presence of various glycosylated and truncated forms. J. Neurochem., 81, 1092 1101.
32. Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., Poser, S., Rojiani, A., Streichemberger, N., Julien, J., Vital, C., Ghetti, B., Gambetti, P. Kretzschmar, H. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol., 46, 224 233.
33. Pauwels, E.K.J., Volterani, D. Marlani, G. (2009) Biomarkers for Alzheimer's disease. Drug News Perspect., 22, 205 213.
34. Perini, F., Vidal, R., Ghetti, B., Tagliavini, F., Frangione, B. Prelli, F. (1996) PrP27-30 is a normal soluble prion protein fragment released by human platelets. Biochem. Biophys. Res. Commun., 223, 572 577.
35. Pham, N., Yin, S., Yu, S., Wong, P., Kang, S.C., Li, C. Sy, M.S. (2008) Normal cellular prion protein with a methionine at position 129 has a more exposed helix 1 and is more prone to aggregate. Biochem. Biophys. Res. Commun., 368, 875 881.
36. Prusiner, S.B. DeArmond, S.J. (1994) Prion diseases and neurodegeneration. Annu. Rev. Neurosci., 17, 311 339.
37. Rogers, M. Taraboulos, A., Scott, M., Groth, D. Prusiner, S.B. (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology, 1, 101 109.
38. Satoh, K., Muramoto, T., Tanaka, T., Kitamoto, N., Ironside, J.W., Nagashima, K., Yamada, M., Sato, T., Mohri, S. Kitamoto, T. (2003) Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases. J. Gen. Virol., 84, 2885 2893.
39. Segarra, C., Lehmann, S. Coste, J. (2009) Prion protein expression and processing in human mononuclear cells: the impact of the codon 129 prion gene polymorphism. PLoS ONE, 4, e5796.
40. Sunyach, C., Cisse, M.A., da Costa, C.A., Vincent, B. Checler, F. (2007) The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependant staurosporine-induced caspase-3 activation. J. Biol. Chem., 282, 1956 1963.
41. Tagliavini, F., Prelli, F., Porro, M., Salmona, M., Bugiani, O. Frangione, B. (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem. Biophys. Res. Commun., 184, 1398 1404.
42. Tapiola, T., Alafuzoff, I., Herukka, S.K., Parkinnen, L., Hartikainen, P., Soininen, H. Pirttilä, T. (2009) Cerebrospinal fluid ß-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol., 66, 382 389.
43. Uro-Coste, E., Cassard, H., Simon, S., Lugan, S., Bilheude, J.M., Perret-Liaude, A., Ironside, J.W., Haik, S., Basset-Leobon, C., Lacroux, C., Peoch, K., Streichenberger, N., Langeveld, J., Head, M.W., Grassi, J., Hauw, J.J., Schelcher, F., Delisle, M.B. Andreoletti, O. (2008) Beyond PrPres type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog., 4, e1000029.
44. Vana, K., Zuber, C., Nikles, D. Weiss, S. (2007) Novel aspects of Prions, their receptor molecules and innovative approaches for TSE therapy. Cell. Mol. Neurobiol., 27, 107 128.
45. Walmsley, A.R., Watt, N.T., Taylor, D.R., Perera, W.S. Hooper, N.M. (2009) Alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol. Cell. Neurosci., 40, 242 248.
46. Watt, N.T. Hooper, N.M. (2005) Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress. Biochem. Soc. Trans., 33, 1123 1125.
47. Watt, N.T., Taylor, D.R., Gillott, A., Thomas, D.A., Perera, W.S. Hooper, N.M. (2005) Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem., 280, 35914 35921.
48. Weller, R.O. (2001) How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's disease. J. Pathol., 194, 1 3.
49. WHO (1998) Humans transmissible spongiform encephalopathies. Wkly Epidemiol. Rec., 47, 361 365.
50. Windl, O., Giese, A., Schulz-Schaeffer, W., Zerr, I., Skworc, K., Arendt, S., Oberdieck, C., Bodemer, M., Poser, S. Kretzschmar, H.A. (1999) Molecular genetics of human prion disease in Germany. Hum. Genet., 105, 244 252.
51. Wong, B.S., Green, A.J., Li, R., Xie, Z., Pan, T., Liu, T., Chen, S.G., Gambetti, P. Sy, M.S. (2001) Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J. Pathol., 194, 9 14.
52. Zanusso, G., Liu, D., Ferrari, S., Hegyi, I., Yin, X., Aguzzi, A., Hornemann, S., Liemann, S., Glockshuber, R., Manson, J.C., Brown, P., Petersen, R.B., Gambetti, P. Sy, M.S. (1998) Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl Acad. Sci. USA, 95, 8812 8816.
53. Zanusso, G., Righetti, P.G., Ferrari, S., Terrin, L., Farinazzo, A., Cardone, F., Pocchiari, M., Rizzuto, N. Monaco, S. (2002) Two-dimensional mapping of three phenotype-associated isoforms of the cellular prion protein in sporadic Creutzfeldt-Jakob disease. Electrophoresis, 23, 347 355.
54. Zanusso, G., Farinazzo, A., Prelli, F., Fiorini, M., Gelati, M., Ferrari, S., Righetti, P.G., Rizzuto, N., Frangione, B. Monaco, S. (2004) Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem., 279, 38936 38942.
55. Zerr, I., Bodemer, M., Otto, M., Poser, S., Windl, O., Kretzschmar, H.A., Gefeller, O. Weber, T. (1996) Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet, 348, 846 849. (Pubitemid 26320899)
56. Zerr, I., Bodemer, M., Gefeller, O., Otto, M., Poser, S., Wiltfang, J., Windl, O., Kretzschmar, H.A. Weber, T. (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol., 43, 32 40.
57. Zerr, I., Pocchiari, M., Collins, S., Brandel, J.P., de Pedro Cuesta, J., Knight, R.S., Bernheimer, H., Cardone, F., Delasnerie-Lauprêtre, N., Cuadrado Corrales, N., Ladogana, A., Bodemer, M., Fletcher, A., Awan, T., Ruiz Bremón, A., Budka, H., Laplanche, J.L., Will, R.G. Poser, S. (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology, 55, 811 815.
58. Zerr, I., Kallenberg, K., Summers, D.M., Romero, C., Taratuto, A., Heinenmann, U., Breithaupt, M., Meissner, B., Ladogana, A., Schuur, M., Haik, S., Collins, S.J., Jansen, G.H., Stokin, G.B., Pimentel, J., Hewer, E., Collie, D., Smith, P., Roberts, H., Brandel, J.B., van Duijn, C., Pocchiari, M., Begue, C., Cras, P., Will, R.G. Sanchez-Juan, P. (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain, 132, 2659 2668.
59. Zou, W.Q., Capellari, S., Parchi, P., Sy, M.S., Gambetti, P. Chen, S.G. (2003) Identification of novel PK resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J. Biol. Chem., 278, 40429 40436.